Source BioScience Announces Appointment to the Board

News Jul 03, 2014

Pam is a Chartered Mechanical Engineer and Fellow of the Royal Academy of Engineering with over 30 years’ experience in the manufacturing and engineering industries. She has significant experience in senior leadership roles across a broad spectrum of companies and other organisations including Chesterfield Royal Foundation Trust Hospital and Sheffield Hallam University. Pam was the first woman to be elected as President of the Institution of Mechanical Engineers and as Master of the Company of Cutlers in Hallamshire.

Laurie Turnbull, Chairman, said: “I am delighted to welcome Pam to the Board. Her considerable knowledge of the manufacturing and engineering industries will be invaluable following the acquisitions of Inverclyde Biologicals and Vindon during 2013. She will also bring experience and an important, additional skill base to the Board as we continue with the implementation of the Group’s growth strategy.”

Further information required to be disclosed: Mandall Engineering Ltd entered into administration in June 2006, while Mrs Liversidge was a director, and was ultimately wound up in March 2008 by means of a creditors’ voluntary liquidation. No further information is required to be disclosed pursuant to paragraph 9.6.13 of the Listing Rules.

Marker Indicates Those at Higher Risk from Lethal Fungal Spores

News

Genetic mutation in humans linked to a 17-fold increase in the amount of dangerous fungal spores in the lungs.

How the Cell Copes With Stress

News

Researchers from the Department of Biochemistry and Molecular Biology at the UAB and from the United Kingdom, for the first time describe the mechanism used by cells to optimise protein production in stressful situations through the altering of tRNA abundance.

Protein Curbs Obesity Through Our Gut Bacteria

News

Scientists from the UNC School of Medicine discovered that the anti-inflammatory protein NLRP12 normally helps protect mice against obesity and insulin resistance when they are fed a high-fat diet. The researchers also reported that the NLRP12 gene is underactive in people who are obese, making it a potential therapeutic target for treating obesity and diabetes.

Like what you just read? You can find similar content on the communities below.

Genomics Research Informatics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free